Fortress Biotech
(NASDAQ) FBIO
Fortress Biotech Financials at a Glance
Market Cap
$72.46M
Revenue (TTM)
$63.25M
Net Income (TTM)
$6.82M
EPS (TTM)
$-0.12
P/E Ratio
-18.83
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Price
$2.25
Volume
5,610
Open
$2.31
Price
$2.25
Volume
5,610
Open
$2.31
Previous Close
$2.25
Daily Range
$2.24 - $2.32
52-Week Range
$1.60 - $4.53
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Price
$2.25
Volume
5,610
Open
$2.31
Previous Close
$2.25
Daily Range
$2.24 - $2.32
52-Week Range
$1.60 - $4.53
FBIO News
Coronado Biosciences Names New CEO
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Fortress Biotech
Industry
Biotechnology
Sector
Health CareEmployees
78
CEO
Lindsay Allan Rosenwald, MD
Website
www.fortressbiotech.comHeadquarters
Bay Harbor Islands, FL 33154, US
FBIO Financials
Key Financial Metrics (TTM)
Gross Margin
67%
Operating Margin
-1%
Net Income Margin
11%
Return on Equity
19%
Return on Capital
-52%
Return on Assets
4%
Earnings Yield
-5.31%
Dividend Yield
0.00%
Payout Ratio
9.74%
Stock Overview
Market Cap
$72.46M
Shares Outstanding
32.20M
Volume
5.61K
Short Interest
0.00%
Avg. Volume
746.06K
Financials (TTM)
Gross Profit
$42.34M
Operating Income
$70.22M
EBITDA
$20.16M
Operating Cash Flow
$65.78M
Capital Expenditure
$0.00
Free Cash Flow
$65.78M
Cash & ST Invst.
$79.38M
Total Debt
$74.30M
Fortress Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$16.07M
+6.3%
Gross Profit
$10.64M
+14.2%
Gross Margin
66.22%
N/A
Market Cap
$72.46M
N/A
Market Cap/Employee
$717.38K
N/A
Employees
101
N/A
Net Income
$3.94M
+41.8%
EBITDA
$3.18M
+85.4%
Quarterly Fundamentals
Net Cash
$5.08M
+127.2%
Accounts Receivable
$29.94M
+187.8%
Inventory
$9.62M
-33.3%
Long Term Debt
$72.17M
-0.7%
Short Term Debt
$2.13M
-34.5%
Return on Assets
3.67%
N/A
Return on Invested Capital
-51.71%
N/A
Free Cash Flow
$12.54M
+2.8%
Operating Cash Flow
$12.54M
+2.8%